|
1
|
Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation.
|
Mol Cell
|
2004
|
2.31
|
|
2
|
Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1.
|
Mol Cell Biol
|
2007
|
1.89
|
|
3
|
CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance.
|
Cell Metab
|
2009
|
1.68
|
|
4
|
Impaired pancreatic growth, beta cell mass, and beta cell function in E2F1 (-/- )mice.
|
J Clin Invest
|
2004
|
1.55
|
|
5
|
Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit.
|
J Biol Chem
|
2003
|
1.52
|
|
6
|
Liver receptor homolog 1 controls the expression of carboxyl ester lipase.
|
J Biol Chem
|
2003
|
1.17
|
|
7
|
Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis.
|
Mol Endocrinol
|
2006
|
1.09
|
|
8
|
Ligand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells.
|
EMBO Rep
|
2004
|
1.01
|
|
9
|
The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.
|
Diabetes
|
2007
|
0.99
|
|
10
|
PPAR-alpha effects on the heart and other vascular tissues.
|
Am J Physiol Heart Circ Physiol
|
2003
|
0.97
|
|
11
|
Cyclin G2 regulates adipogenesis through PPAR gamma coactivation.
|
Endocrinology
|
2010
|
0.91
|
|
12
|
Cell cycle regulators in the control of metabolism.
|
Cell Cycle
|
2009
|
0.91
|
|
13
|
The RIP140 gene is a transcriptional target of E2F1.
|
PLoS One
|
2012
|
0.89
|
|
14
|
PPAR agonists in the treatment of atherosclerosis.
|
Curr Opin Pharmacol
|
2003
|
0.88
|
|
15
|
Regulator of G protein signaling-4 controls fatty acid and glucose homeostasis.
|
Endocrinology
|
2008
|
0.86
|
|
16
|
E2F transcription factor-1 deficiency reduces pathophysiology in the mouse model of Duchenne muscular dystrophy through increased muscle oxidative metabolism.
|
Hum Mol Genet
|
2012
|
0.84
|
|
17
|
Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance.
|
Cancer Cell
|
2016
|
0.78
|
|
18
|
E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis.
|
J Clin Invest
|
2015
|
0.78
|
|
19
|
The CDK4-pRB-E2F1 pathway : A new modulator of insulin secretion.
|
Islets
|
2010
|
0.77
|
|
20
|
CDK4, pRB and E2F1: connected to insulin.
|
Cell Div
|
2010
|
0.77
|
|
21
|
[Emerging key role of cell cycle regulators in cell metabolism].
|
Med Sci (Paris)
|
2011
|
0.76
|
|
22
|
E2F1 at the crossroad of proliferation and oxidative metabolism.
|
Cell Cycle
|
2011
|
0.76
|
|
23
|
CDK4 is an essential insulin effector in adipocytes.
|
J Clin Invest
|
2015
|
0.75
|